Insulet

IPO

Born of empathy, driven by ingenuity, proven by science

Public · Acton, United States · Founded 2000 · $103.0M raised

Employees
1001–5000
Founded
2000
Business Model
B2B2C
Total Funding
$103.0M
Last Round
$50.0M Series EFeb 2006
Rounds
5
Type
Public

About

Insulet Corporation (NASDAQ: PODD) is an innovative medical device company headquartered in Acton, Massachusetts, dedicated to transforming the lives of people with diabetes and other conditions through its Omnipod product platform. Founded in 2000, Insulet pioneered the tubeless, waterproof Omnipod insulin pump system, which eliminates the need for multiple daily injections and the tubing associated with traditional pumps. The Omnipod 5 is the first tubeless automated insulin delivery system. Insulet's products are accessible in 25 countries across North America, Europe, the Middle East, and Asia Pacific.

Summary

Insulet is a Healthcare company based in Acton, United States, founded in 2000. It has raised $103.0M in total across 5 rounds, most recently a $50.0M Series E round in Feb 2006. Investors include Prism Venture Partners, Kodiak Venture Partners and OrbiMed.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOMay 2007
$120.0M

Sign up to see all 6 rounds

Seed through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Insulet on Indexed.vc
<a href="https://indexed.vc/companies/insulet"><img src="https://indexed.vc/api/badge/company/insulet" alt="Insulet on Indexed.vc" width="260" height="76" /></a>